The European Medicines Agency says that it is putting certain lower-priority activities on hold and may need to divert resources away from activities planned for 2018 so that it can prepare for its Brexit-related relocation and focus on its core tasks.
Keeping its operations running smoothly and retaining as many staff as possible during the move is a key priority for...